Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent

被引：0
|
作者：
M. Panisset
S. Gauthier
H. Moessler
M. Windisch
机构：
[1]  McGill Centre for Studies in Ageing,
[2] Montreal,undefined
[3] Canada,undefined
[4] EBEWE Arzneimittel GmbH,undefined
[5] Unterach,undefined
[6] and,undefined
[7] JSW Research,undefined
[8] Graz,undefined
[9] Austria,undefined
来源：
Journal of Neural Transmission | 2002年 / 109卷
关键词：
Keywords: Alzheimer's disease; Cerebrolysin; neurodegeneration; neurotrophic factors; peptide derivative.;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1089 / 1104
页数：15
相关论文
共 50 条
  • [21] A Randomized, Double-Blind, Placebo-Controlled Trial of Pridopidine in Huntington's Disease
    Kieburtz, Karl
    McGarry, Andrew
    McDermott, Michael
    Kayson, Elise
    Harrison, Madaline
    Marder, Karen
    Walker, Francis
    MOVEMENT DISORDERS, 2013, 28 (10) : 1407 - 1415
  • [22] Efficacy of FPF 1070 (cerebrolysin) in patients with Alzheimer's disease. A multicentre, randomised, double-blind, placebo-controlled trial
    Shifu X.
    Heqin Y.
    Peifen Y.
    Luning W.
    Jianjun J.
    Xin M.
    Feng B.
    Jie L.
    Chunxie W.
    Zhihua D.
    Mingyi Z.
    Wenzhen X.
    Yinglu G.
    Cui M.
    Daping W.
    Binhua S.
    Clinical Drug Investigation, 2000, 19 (1) : 43 - 53
  • [23] Cerebrolysin and Recovery After Stroke (CARS) A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
    Muresanu, Dafin F.
    Heiss, Wolf-Dieter
    Hoemberg, Volker
    Bajenaru, Ovidiu
    Popescu, Cristian Dinu
    Vester, Johannes C.
    Rahlfs, Volker W.
    Doppler, Edith
    Meier, Dieter
    Moessler, Herbert
    Guekht, Alla
    STROKE, 2016, 47 (01) : 151 - 159
  • [24] DHEA treatment of Alzheimer's disease - A randomized, double-blind, placebo-controlled study
    Wolkowitz, OM
    Kramer, JH
    Reus, VI
    Costa, MM
    Yaffe, K
    Walton, P
    Raskind, M
    Peskind, E
    Newhouse, P
    Sack, D
    De Souza, E
    Sadowsky, C
    Roberts, E
    NEUROLOGY, 2003, 60 (07) : 1071 - 1076
  • [25] ETANERCEPT IN ALZHEIMER DISEASE: A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 2 TRIAL Response
    Holmes, Clive
    NEUROLOGY, 2015, 85 (23) : 2084 - 2084
  • [26] Journal Club: A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease
    Pressman, Peter
    Gottfried, Jay A.
    NEUROLOGY, 2012, 79 (04) : E33 - E36
  • [27] A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Richard, I. H.
    McDermott, M. P.
    Kurlan, R.
    Lyness, J. M.
    Como, P. G.
    Pearson, N.
    Factor, S. A.
    Juncos, J.
    Ramos, C. Serrano
    Brodsky, M.
    Manning, C.
    Marsh, L.
    Shulman, L.
    Fernandez, H. H.
    Black, K. J.
    Panisset, M.
    Christine, C. W.
    Jiang, W.
    Singer, C.
    Horn, S.
    Pfeiffer, R.
    Rottenberg, D.
    Slevin, J.
    Elmer, L.
    Press, D.
    Hyson, H. C.
    McDonald, W.
    NEUROLOGY, 2012, 78 (16) : 1229 - 1236
  • [28] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [29] Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease
    Martinuzzi, Andrea
    Liava, Alexandra
    Trevisi, Enrico
    Frare, Mara
    Tonon, Caterina
    Malucelli, Emil
    Manners, David
    Kemp, Graham J.
    Testa, Claudia
    Barbiroli, Bruno
    Lodi, Raffaele
    MUSCLE & NERVE, 2008, 37 (03) : 350 - 357
  • [30] Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
    Sandborn, WJ
    Hanauer, SB
    Katz, S
    Safdi, M
    Wolf, DG
    Baerg, RD
    Tremaine, WJ
    Johnson, T
    Diehl, NN
    Zinsmeister, AR
    GASTROENTEROLOGY, 2001, 121 (05) : 1088 - 1094
12345